The Valley Desk

ArticleTherapeutic advances in neurological disordersPublished

Comparative effectiveness and safety of ozanimod versus other oral DMTs in relapsing-remitting multiple sclerosis: a synthesis of matching-adjusted indirect comparisons

Read the publication ↗ Open access copy ↗

Regional connection

Listed An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source

Publication record

Type
Article
Venue
Therapeutic advances in neurological disorders
Published
Subject terms
Fingolimod; Teriflunomide; Relapsing-remitting Multiple Sclerosis; Ponesimod; Matching-adjusted Indirect Comparison; Ozanimod
PubMed ID
38855023
PubMed Central ID
PMC11162124
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal